| |
original article |
Date |
Title |
Authors All Authors |
| 1 |
[GO] |
2026―Jan―22 |
Letter to the Editor:
A Lesson for the Future-How Semantic Ambiguity Led to
the Spread of Anti-Scientific Attitudes About COVID-19 mRNA Vaccines |
Amir Asaleh, Jichun Zhou, Narges Rahmanian |
| 2 |
[GO] |
2022―Jan―21 |
In vivo HSC gene therapy for SARS-CoV2 infection using a decoy receptor |
Hongjie Wang, chang Li, Adebimpe Obadan, Hannah Frizzell, Tien-Ying Hsiang, Sucheol Gil, et al. (+7) Audrey Germond, Connie Fountain, Audrey Baldessari, Steve Roffler, Hans-Peter Kiem, Deborah Fuller, Andre Lieber |
| 3 |
[GO] |
2021―Jul―20 |
Immune Responses to Recombinant Adenoviruses As Gene Therapy Vectors and COVID-19 Vaccines: A Two-Edged Sword |
Terence R. Flotte, Guangping Gao |
| 4 |
[GO] |
2021―Apr―16 |
Current update on SARS-CoV-2 vaccine development with a special emphasis on gene therapy viral vector design and construction for vaccination |
Atil Bisgin, Ahter D. Sanlioglu, Yunus E. Eksi, Thomas S. Griffith, Salih Sanlioglu |
| 5 |
[GO] |
2021―Jan―08 |
Clinical course and risk factors of disease deterioration in critically ill patients with COVID-19 |
Wei-dong Qin, Wenwu Bai, keyin Liu, Ya Liu, Xiao Meng, Kai Zhang, Mingxiang Zhang |
| 6 |
[GO] |
2020―May―29 |
COVID-19: Gene Transfer to the Rescue? |
Luk H. Vandenberghe |
| 7 |
[GO] |
2020―May―19 |
The Impact of the COVID-19 Pandemic on the Biotech Industry |
Philip Reilly |
| 8 |
[GO] |
2020―Mar―26 |
A Message to Our Community in the Midst of the COVID-19 Pandemic |
Terence R. Flotte |
